Search
-
Luye Life Sciences Launches Innovative Vaccine and Biotechnology Center Project in Uzbekistan
On September 7, 2023, Luye Life Sciences Group, in collaboration with the Ministry of Higher Education, Science, and Innovation of Uzbekistan, celebrated a signing ceremony in Tashkent for their joint...
2023-09-11
MORE>
-
Luye Pharma Announces 2023 Half Year Results
Remarkable payoff for innovationStrong revenue growthAccelerated commercialization worldwideLuye Pharma Group (2186.HK) announced its 2023 half year results and recent developments on August 29, 2023....
2023-08-30
MORE>
-
Boan Biotech Announces 2023 Half Year Results
Boan Biotech (6955.HK) announced its 2023 half year results and recent developments on August 27, 2023.Highlights of2023 half year resultsRobust revenue growthIn the first half of 2023, the company&rs...
2023-08-29
MORE>
-
China’s NMPA Accepts and Grants Priority Review Designation to the New Drug Application for Luye Pharma’s Rotigotine Extended-Release Microspheres
August 1, 2023 – Luye Pharma Group today announced that the New Drug Application (NDA) of its weekly-dosed Rotigotine Extended-Release Microspheres for Injection (LY03003) for the treatment of P...
2023-08-02
MORE>
-
Goserelin Microspheres for Injection Approved for Launch in China
-Luye Pharma and BeiGene announce a strategic partnership for the commercialization of this product, the only one in the world--Providing a new ADT that is effective and safe with a better experience ...
2023-07-05
MORE>
-
Patient Enrollment Completed for Phase III Clinical Trial of Boan Biotech’s Dulaglutide Injection BA5101 in China
Yantai, May 15, 2023– Boan Biotech today announced the completion of patient enrollment for the Phase III clinical trial (a comparative clinical study of efficacy and safety) of the company&rsqu...
2023-05-16
MORE>
-
Luye Pharma Announces 2022 Financial Results
- Company embarks on high-quality growth across the globe drivenby growing revenue and profit with the approval of several new drugs -Yantai, China, March 29, 2023 -Luye Pharma Group (2186.HK) today a...
2023-03-30
MORE>
-
Boan Biotech Announces 2022 Financial Results
Boan Biotech (6955.HK) announced its 2022 financial results and recent business developments on March 27, 2023.2022 business highlightsRecord high in revenueIn 2022, Boan Biotech's revenue was app...
2023-03-29
MORE>
-
BLA Accepted in China for Boan Biotech’s Denosumab Injection (BA1102) for the Oncology Indications
Yantai, China, March 21, 2023 —Luye Pharma Group today announced that the Biologics License Application (BLA) for BA1102 (Denosumab Injection), a biosimilar for the oncology indications developed by ...
2023-03-21
MORE>
-
Patient Enrollment Completed for BA9101 Phase 3 Clinical Study
Boan Biotech today announced that patient enrollment has been completed for the Phase 3 clinical study (comparative clinical study of efficacy and safety) of BA9101 (Aflibercept Intravitreous Injectio...
2023-03-14
MORE>
var _hmt = _hmt || [];
(function() {
var hm = document.createElement("script");
hm.src = "https://hm.baidu.com/hm.js?90c4d9819bca8c9bf01e7898dd269864";
var s = document.getElementsByTagName("script")[0];
s.parentNode.insertBefore(hm, s);
})();
!function(p){"use strict";!function(t){var s=window,e=document,i=p,c="".concat("https:"===e.location.protocol?"https://":"http://","sdk.51.la/js-sdk-pro.min.js"),n=e.createElement("script"),r=e.getElementsByTagName("script")[0];n.type="text/javascript",n.setAttribute("charset","UTF-8"),n.async=!0,n.src=c,n.id="LA_COLLECT",i.d=n;var o=function(){s.LA.ids.push(i)};s.LA?s.LA.ids&&o():(s.LA=p,s.LA.ids=[],o()),r.parentNode.insertBefore(n,r)}()}({id:"K9y7iMpaU8NS42Fm",ck:"K9y7iMpaU8NS42Fm"});
one体育-艾尚体育
沐鸣平台_沐鸣平台科技_沐鸣平台厂家_沐鸣平台企业
力量体育app_官网-力量体育app
one体育-官网app下载
im电竞官网app